A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

NCT00520572 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

385

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: AZD9056
DRUG: Etanercept
DRUG: Placebo

Sponsor

AstraZeneca